Match the items on the right with the items on the left.

Associated with release of histamine, ATP and other mediators	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
immediate allergic reaction	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
Receptor through which histamine inhibits lysosomal content release	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
Histamine receptor type: increases phosphoinositol hydrolysis	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
Histamine increases gastric acid secretion by acting on these cells:	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
Histamine effect on bronchiolar smooth muscle	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
H1 antagonists' antiParkinsonism effect is probably associated with this receptor system:	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
Interactions between terfenidine and this drug may cause significant cardiotoxicity.	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I
Example of second-generation H1 antihistaminic:	??? H1 itraconazole fexofenadine H2 degranulation muscarinic cholinergic parietal cells bronchoconstriction type I